ContextVision AB (COV.OL)


Oslo - Oslo Delayed Price. Currency in NOK
38.300.00 (0.00%)
At close: 4:46 AM EDT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open38.30
Prev Close38.30
Bid37.00 x 140000
Ask38.30 x 140000
Day's Range38.30 - 38.30
52wk Range20.00 - 38.50
1y Target EstN/A
Market Cap296.32M
P/E Ratio (ttm)671.93
BetaN/A
Volume0
Avg Vol (3m)882
Dividend & YieldN/A (N/A)
Earnings DateN/A
  • ContextVision AB : Fairly valued, but don’t skip the other factors
    Capital Cubelast month

    ContextVision AB : Fairly valued, but don’t skip the other factors

    ContextVision AB relative valuation is now NEUTRAL. It was previously rated UNDERVALUED, and has a fundamental analysis score of 50.Our analysis is based on comparing ContextVision AB with the following peers – MedicPen AB, Biotage AB and CellaVision AB (MPEN-SE, BIOT-SE and CEVI-SE).Relative ValuationContextVision AB is currently neutrally valued, as its previous close of NOK […] (Read more...) The post ContextVision AB : Fairly valued, but don’t skip the other factors appeared first on CapitalCube.

  • ContextVision AB : Undervalued relative to peers, but don’t ignore the other factors
    Capital Cubelast year

    ContextVision AB : Undervalued relative to peers, but don’t ignore the other factors

    ContextVision AB relative valuation is now UNDERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 57.Our analysis is based on comparing ContextVision AB with the following peers – MedicPen AB, Biotage AB and CellaVision AB (MPEN-SE, BIOT-SE and CEVI-SE).Relative ValuationContextVision AB’s price of NOK 22.90 is lower than CapitalCube’s implied price (Read more...) The post ContextVision AB : Undervalued relative to peers, but don’t ignore the other factors appeared first on CapitalCube.

  • We're sorry this is all we were able to find about this topic.